MD, MPH, PhD, FESC, a Pediatric Clinical Epidemiologist and Principal Investigator of “urFIT-child” research group, University of Eastern Finland (Finland) & University of Exeter (UK) is receiving the Award for discovering arterial stiffness as a novel risk factor for pediatric obesity and insulin resistance, identifying critical time to interrupt fat mass-insulin resistance pathologic cycle, and demonstrating light-intensity physical activity as a highly effective antidote for reversing excessive fat deposit induced by childhood sedentariness.
The Novo Nordisk Foundation has provided support to the European Association for the Study of Obesity (EASO) for Early Career Network development activities. The Novo Nordisk Foundation has had no influence over award selection or meeting agendas.